lacosamide
NDC 68462-681, lacosamide, tablet, film coated, from Glenmark Pharmaceuticals Inc. USA.
- Product NDC
- 68462-681
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc. USA
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205006
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/68462-681 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE200 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-681-10 | 68462068110 | 1000 TABLET, FILM COATED in 1 BOTTLE (68462-681-10) |
| 68462-681-30 | 68462068130 | 30 TABLET, FILM COATED in 1 BOTTLE (68462-681-30) |
| 68462-681-60 | 68462068160 | 60 TABLET, FILM COATED in 1 BOTTLE (68462-681-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/df1d2e6a-6129-49c9-b2c1-0fdf73f38b9cNADAC price for package 68462068160
GET /v1/drugs/nadac/68462068160
Use it
Look up 68462-681 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-681 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-681. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.